Tag Archive for: MDR bacteria; AMR

Under a high magnification of 10,000X, this digitally-colorized scanning electron microscopic (SEM) image shows a strain of Staphylococcus aureus bacteria taken from a vancomycin intermediate resistant culture (VISA). © CDC/Janice Haney Carr
Collaboration

LimmaTech Biologics acquires licence option for AbVacc vaccine LBT-SA7

Swiss LimmaTech Biologics and AbVacc Inc have agreed to co-develop AbVacc’s preclinical Staphylococcus aureus vaccine LBT-SA7 (formerly IBT-V02) in case of Phase I success.

Read more